Message #1 From:
Jason Date: June 3, 2007 09:15:43 PM
ARNA, Arena Pharmaceuticals to Present at Citigroup's Global Healthcare Conference
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA Forum Stocks) announced today that the company is scheduled to present at Citigroup's Global Healthcare Conference on May 24, 2007 at 11:00 a.m. Eastern Time (8:00 a.m. Pacific Time) at the Hilton New York Hotel in New York City. Dominic P. Behan, Ph.D., Arena's Senior Vice President and Chief Scientific Officer, is scheduled to provide a corporate overview of the company and its clinical development and discovery programs.
A live audio webcast of the presentation will be available under the investor relations section of Arena's website at www.arenapharm.com. A replay of the presentation will be available for 30 days following the event. Please connect to Arena's website several minutes prior to the start of the webcast to ensure adequate time for any software download that may be necessary.
About ARNA Arena Pharmaceuticals
Arena is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory, and metabolic diseases. Arena's most advanced product candidate, lorcaserin, is being investigated in a Phase 3 clinical trial program for the treatment of obesity. Arena's broad pipeline of novel compounds targeting G protein-coupled receptors, an important class of validated drug targets, includes compounds being evaluated independently and with its partners, Merck & Co., Inc. and Ortho-McNeil Pharmaceutical, Inc.
